A citation-based method for searching scientific literature

P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki, Rajiv Kumar. Proc Natl Acad Sci U S A 2013
Times Cited: 209







List of co-cited articles
1109 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Genetic Evolution of Melanoma from Precursor Lesions.
A Hunter Shain, Iwei Yeh, Ivanka Kovalyshyn, Aravindhan Sriharan, Eric Talevich, Alexander Gagnon, Reinhard Dummer, Jeffrey North, Laura Pincus, Beth Ruben,[...]. N Engl J Med 2015
459
7

Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.
Muhammad Khairul Ramlee, Jing Wang, Wei Xun Toh, Shang Li. Genes (Basel) 2016
70
10

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Stig E Bojesen, Karen A Pooley, Sharon E Johnatty, Jonathan Beesley, Kyriaki Michailidou, Jonathan P Tyrer, Stacey L Edwards, Hilda A Pickett, Howard C Shen, Chanel E Smart,[...]. Nat Genet 2013
383
7

A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study.
Pedro Castelo-Branco, Ricardo Leão, Tatiana Lipman, Brittany Campbell, Donghyun Lee, Aryeh Price, Cindy Zhang, Abolfazl Heidari, Derek Stephens, Stefan Boerno,[...]. Oncotarget 2016
37
18


Whole-genome landscapes of major melanoma subtypes.
Nicholas K Hayward, James S Wilmott, Nicola Waddell, Peter A Johansson, Matthew A Field, Katia Nones, Ann-Marie Patch, Hojabr Kakavand, Ludmil B Alexandrov, Hazel Burke,[...]. Nature 2017
503
7

TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.
M Labussière, A L Di Stefano, V Gleize, B Boisselier, M Giry, S Mangesius, A Bruno, R Paterra, Y Marie, A Rahimian,[...]. Br J Cancer 2014
101
7

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors.
C Billerey, D Chopin, M H Aubriot-Lorton, D Ricol, S Gil Diez de Medina, B Van Rhijn, M P Bralet, M A Lefrere-Belda, J B Lahaye, C C Abbou,[...]. Am J Pathol 2001
344
7

Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.
Doreen N Palsgrove, Diana Taheri, Simeon U Springer, Morgan Cowan, Gunes Guner, Maria A Mendoza Rodriguez, Maria Del Carmen Rodriguez Pena, Yuxuan Wang, Isaac Kinde, Bernardo F P Ricardo,[...]. Hum Pathol 2019
19
36


TERT promoter mutation subtypes and survival in stage I and II melanoma patients.
Juan J Andrés-Lencina, Sivaramakrishna Rachakonda, Zaida García-Casado, Nalini Srinivas, Alexander Skorokhod, Celia Requena, Virtudes Soriano, Rajiv Kumar, Eduardo Nagore. Int J Cancer 2019
21
33

Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
171
7

Telomerase catalytic subunit homologs from fission yeast and human.
T M Nakamura, G B Morin, K B Chapman, S L Weinrich, W H Andrews, J Lingner, C B Harley, T R Cech. Science 1997
6

Extension of life-span by introduction of telomerase into normal human cells.
A G Bodnar, M Ouellette, M Frolkis, S E Holt, C P Chiu, G B Morin, C B Harley, J W Shay, S Lichtsteiner, W E Wright. Science 1998
6

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.
Marc Remke, Vijay Ramaswamy, John Peacock, David J H Shih, Christian Koelsche, Paul A Northcott, Nadia Hill, Florence M G Cavalli, Marcel Kool, Xin Wang,[...]. Acta Neuropathol 2013
99
6

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
Young Shin Song, Jung Ah Lim, Hoonsung Choi, Jae-Kyung Won, Jae Hoon Moon, Sun Wook Cho, Kyu Eun Lee, Young Joo Park, Ka Hee Yi, Do Joon Park,[...]. Cancer 2016
87
6

Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.
Sheila A Stewart, William C Hahn, Benjamin F O'Connor, Elisa N Banner, Ante S Lundberg, Poonam Modha, Hana Mizuno, Mary W Brooks, Mark Fleming, Drazen B Zimonjic,[...]. Proc Natl Acad Sci U S A 2002
352
6


Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.
Ren-Chin Wu, Ayse Ayhan, Daichi Maeda, Kyu-Rae Kim, Blaise A Clarke, Patricia Shaw, Michael Herman Chui, Barry Rosen, Ie-Ming Shih, Tian-Li Wang. J Pathol 2014
60
10

The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis.
Imke Listerman, Jie Sun, Francesca S Gazzaniga, Jason L Lukas, Elizabeth H Blackburn. Cancer Res 2013
98
6

Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC.
Jonathan R George, Ying C Henderson, Michelle D Williams, Dianna B Roberts, Hu Hei, Stephen Y Lai, Gary L Clayman. J Clin Endocrinol Metab 2015
44
13

Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.
Elisabetta Macerola, Barbara Loggini, Riccardo Giannini, Giulia Garavello, Mirella Giordano, Agnese Proietti, Cristina Niccoli, Fulvio Basolo, Gabriella Fontanini. Virchows Arch 2015
39
15


TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma.
Hong Xie, Tiantian Liu, Na Wang, Viveca Björnhagen, Anders Höög, Catharina Larsson, Weng-Onn Lui, Dawei Xu. Oncotarget 2014
40
15

Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression.
Ekta Khattar, Pavanish Kumar, Chia Yi Liu, Semih Can Akıncılar, Anandhkumar Raju, Manikandan Lakshmanan, Julien Jean Pierre Maury, Yu Qiang, Shang Li, Ern Yu Tan,[...]. J Clin Invest 2016
79
7

Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
S Kyo, M Takakura, T Taira, T Kanaya, H Itoh, M Yutsudo, H Ariga, M Inoue. Nucleic Acids Res 2000
391
6

Prognostic Value of TERT Alterations, Mutational and Copy Number Alterations Burden in Urothelial Carcinoma.
Sumit Isharwal, François Audenet, Esther Drill, Eugene J Pietzak, Gopa Iyer, Irina Ostrovnaya, Eugene Cha, Timothy Donahue, Maria Arcila, Gowtham Jayakumaran,[...]. Eur Urol Focus 2019
16
37

Frequency of TERT Promoter Mutations in Prostate Cancer.
Robert Stoehr, Helge Taubert, Ulrike Zinnall, Johannes Giedl, Nadine T Gaisa, Maximilian Burger, Petra Ruemmele, Carolyn D Hurst, Margaret A Knowles, Bernd Wullich,[...]. Pathobiology 2015
27
22

Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.
Isabelle Guilleret, Pu Yan, Fabienne Grange, Richard Braunschweig, Fred T Bosman, Jean Benhattar. Int J Cancer 2002
173
6

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
Klaus G Griewank, Rajmohan Murali, Bastian Schilling, Tobias Schimming, Inga Möller, Iris Moll, Marion Schwamborn, Antje Sucker, Lisa Zimmer, Dirk Schadendorf,[...]. PLoS One 2013
57
10

Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.
Francesca Pezzuto, Francesco Izzo, Luigi Buonaguro, Clorinda Annunziata, Fabiana Tatangelo, Gerardo Botti, Franco M Buonaguro, Maria Lina Tornesello. Oncotarget 2016
29
20

TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas.
Hideyuki Arita, Yoshitaka Narita, Hirokazu Takami, Shintaro Fukushima, Yuko Matsushita, Akihiko Yoshida, Yasuji Miyakita, Makoto Ohno, Soichiro Shibui, Koichi Ichimura. Acta Neuropathol 2013
45
13

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.
Yasushi Totoki, Kenji Tatsuno, Kyle R Covington, Hiroki Ueda, Chad J Creighton, Mamoru Kato, Shingo Tsuji, Lawrence A Donehower, Betty L Slagle, Hiromi Nakamura,[...]. Nat Genet 2014
407
6

Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.
Morgan L Cowan, Simeon Springer, Doreen Nguyen, Diana Taheri, Gunes Guner, Maria Angelica Mendoza Rodriguez, Yuxuan Wang, Isaac Kinde, Maria Del Carmen Rodriguez Pena, Christopher J VandenBussche,[...]. Hum Pathol 2016
22
27

Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.
Rossana Critelli, Francesca Fasanelli, Marco Oderda, Silvia Polidoro, Manuela Bianca Assumma, Clara Viberti, Mirko Preto, Paolo Gontero, Giuseppina Cucchiarale, Irene Lurkin,[...]. Oncotarget 2016
29
20

High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
Doreen Nguyen, Diana Taheri, Simeon Springer, Morgan Cowan, Gunes Guner, Maria Angelica Mendoza Rodriguez, Yuxuan Wang, Isaac Kinde, Christopher J VandenBussche, Matthew T Olson,[...]. Virchows Arch 2016
25
24

Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma.
Chul-Kee Park, Se-Hoon Lee, Ji Young Kim, Ja Eun Kim, Tae Min Kim, Soon-Tae Lee, Seung Hong Choi, Sung-Hye Park, Il Han Kim. Oncotarget 2014
36
16

Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene.
S Renaud, D Loukinov, Z Abdullaev, I Guilleret, F T Bosman, V Lobanenkov, J Benhattar. Nucleic Acids Res 2007
132
6

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.
Wing-Kin Sung, Hancheng Zheng, Shuyu Li, Ronghua Chen, Xiao Liu, Yingrui Li, Nikki P Lee, Wah H Lee, Pramila N Ariyaratne, Chandana Tennakoon,[...]. Nat Genet 2012
537
6

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
77
7

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.
Simeon U Springer, Chung-Hsin Chen, Maria Del Carmen Rodriguez Pena, Lu Li, Christopher Douville, Yuxuan Wang, Joshua David Cohen, Diana Taheri, Natalie Silliman, Joy Schaefer,[...]. Elife 2018
66
9

Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation.
Ilaria J Russo, Yongwon Ju, Naheema S Gordon, Maurice P Zeegers, K K Cheng, Nicholas D James, Richard T Bryan, Douglas G Ward. Bladder Cancer 2018
22
27

Novel anticancer therapeutics targeting telomerase.
Maria Ruden, Neelu Puri. Cancer Treat Rev 2013
188
6

Telomere Maintenance Mechanisms in Cancer.
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, Manuel Sobrinho-Simões, Paula Soares, João Vinagre. Genes (Basel) 2018
43
13

Role of telomeres and telomerase in cancer.
Jerry W Shay, Woodring E Wright. Semin Cancer Biol 2011
295
5


Regulation of the human catalytic subunit of telomerase (hTERT).
Michael Daniel, Gregory W Peek, Trygve O Tollefsbol. Gene 2012
170
5

Recurrent somatic mutations in regulatory regions of human cancer genomes.
Collin Melton, Jason A Reuter, Damek V Spacek, Michael Snyder. Nat Genet 2015
158
5


The telomerase reverse transcriptase regulates chromatin state and DNA damage responses.
Kenkichi Masutomi, Richard Possemato, Judy M Y Wong, Jennifer L Currier, Zuzana Tothova, Judith B Manola, Shridar Ganesan, Peter M Lansdorp, Kathleen Collins, William C Hahn. Proc Natl Acad Sci U S A 2005
253
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.